浩欧博 (688656.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

69.6x

Market Cap

CNY 6.03B

MomentumView details →

1D Return

−6.78%

YTD Return

—

RSI (14)

61.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

69.6x

Market Cap

CNY 6.03B

RSI (14)

61.1

MomentumView details →

1D Return

−6.78%

YTD Return

—

ProfitabilityView details →

Gross Margin

58.17%

Net Margin

5.44%

EBITDA Margin

23.76%

ROE (TTM)

2.63%

ROA (TTM)

2.38%

Asset Turnover

0.43x

GrowthView details →

Revenue YoY

+1.34%

EPS YoY

−38.16%

FCF YoY

+334.89%

Revenue CAGR 3Y

+7.53%

EPS CAGR 3Y

−17.54%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.26

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.04x

Current Ratio

2.75x

Quick Ratio

1.40x

Div Yield

0.19%

Div Rate

CNY 0.20

Div Growth 1Y

−33.33%

Financials snapshotView financials →

Revenue (TTM)

399.65M

Net Income (TTM)

21.74M

Op. CF (TTM)

73.68M

Latest newsMore news →

HOB Biotech Group announced its 2026 half-year results with net profit of 16.6776 million yuan, up 37.05% year-on-year.18d ago

Similar companies

LifeTech Scientific Corporation01302.HK AK Medical Holdings Limited01789.HK 春立医疗688236.SH Zylox-Tonbridge Medical Technology Co., Ltd.02190.HK 赛诺医疗688108.SH 新华医疗600587.SH Find similar companies →

Latest newsMore news →

HOB Biotech Group announced its 2026 half-year results with net profit of 16.6776 million yuan, up 37.05% year-on-year.18d ago